Detalles de la búsqueda
1.
Multi-level prediction of substance use: Interaction of white matter integrity, resting-state connectivity and inhibitory control measured repeatedly in every-day life.
Addict Biol
; 29(5): e13400, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38706091
2.
Current (but not ex) cigarette smoking is associated with worse cognitive performances in schizophrenia: results from the FACE-SZ cohort.
Psychol Med
; 53(11): 5279-5290, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36073848
3.
History of learning disorders is associated with worse cognitive and functional outcomes in schizophrenia: results from the multicentric FACE-SZ cross-sectional dataset.
Eur Arch Psychiatry Clin Neurosci
; 273(8): 1773-1783, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36583738
4.
The puzzle of quality of life in schizophrenia: putting the pieces together with the FACE-SZ cohort.
Psychol Med
; 52(8): 1501-1508, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32962773
5.
Real-time cognitive performance and positive symptom expression in schizophrenia.
Eur Arch Psychiatry Clin Neurosci
; 272(3): 415-425, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34287696
6.
Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ).
Eur Arch Psychiatry Clin Neurosci
; 272(7): 1273-1282, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35441901
7.
Relationship between neurocognition and theory of mind as a function of symptomatic profile in schizophrenia: results from the national FACE-SZ cohort.
Cogn Neuropsychiatry
; 27(1): 49-68, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34882065
8.
Assessing metacognitive and help-seeking strategies in schizophrenia: design and psychometric validation of the Versailles Metacognitive Strategies Evaluation Questionnaire.
Clin Rehabil
; 34(2): 263-275, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31795759
9.
Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort.
Br J Psychiatry
; 213(2): 464-470, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29871707
10.
Feasibility and validity of mobile cognitive testing in patients with substance use disorders and healthy controls.
Am J Addict
; 27(7): 553-556, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30260085
11.
Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset.
Eur Arch Psychiatry Clin Neurosci
; 267(6): 567-577, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28389889
12.
Clinical and cognitive characteristics of subjects with schizophrenia and childhood attention-deficit/hyperactivity disorder: Results from the multicentric FACE-SZ cross-sectional dataset.
Schizophr Res
; 264: 105-112, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38128341
13.
Psychometric Assessment of an Item Bank for Adaptive Testing on Patient-Reported Experience of Care Environment for Severe Mental Illness: Validation Study.
JMIR Ment Health
; 11: e49916, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38753416
14.
Family psychoeducation to improve outcome in caregivers and patients with schizophrenia: a randomized clinical trial.
Front Psychiatry
; 14: 1171661, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37426102
15.
Mood Variability, Craving, and Substance Use Disorders: From Intrinsic Brain Network Connectivity to Daily Life Experience.
Biol Psychiatry Cogn Neurosci Neuroimaging
; 8(9): 940-955, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36775712
16.
Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders.
Addict Neurosci
; 92023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38389954
17.
Poverty and inequality in real-world schizophrenia: a national study.
Front Public Health
; 11: 1182441, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38026279
18.
Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia.
Schizophr Res
; 252: 48-55, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36623435
19.
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset.
Transl Psychiatry
; 13(1): 341, 2023 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37935695
20.
Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs.
BMJ Ment Health
; 26(1)2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37852631